Member Info for ZzTop1

Highly unlikely as too obvious so don't get too excited

Mofofreeman's a serial trader playing the 2% swings. Sometimes he hits and at others he misses. You're unlikely to get a straight answer to your question and even if you do it'll be b0ll0x

Well I hate to come between a good scrap but this one's fookin boring so I'm off outta here. Back to good old fashioned ramping and deramping tomorrow and less of this gangsta sheet innit. Gla

Sujood is our friendly and harmless ramping bb bot. It just keeps everyone pleasantly positive. Still an early version, being fine-tuned. There was an alternative version recently released for testing named Poundcake which failed field testing so been called back in and will be re-released under a new name coming soon.

Testing here to stay for the foreseeable:

https://www.theguardian.com/society/2020/nov/28/oxford-controversy-is-the-first-shot-in-international-battle-over-vaccine-efficiency

As soon as there's even a whiff of takeover talk here the sp will move swiftly. For now Al's trying to get the hedgefunds and investors on-board. Rouane are in first ahead of human trials. The others will be queuing around the block to get in assuming trials go well next year. Get some covid tests outta the door and the investment case becomes a whole heap more appealing

Can't go into detail but mega labs not looking at MS right now. The capacity is planned on available tech. Not to say that won't change. MS is for hospitals and potentially universities if they're currently testing Bams, in my view

Feck me, let's sell an lfd first

It's not so vague here, it's now been 5 weeks so we're stretching the definition of 'next few weeks':

Q11: Please could you give a full update on where the company and CONDOR are at with both the BAMS test and LFD? Timelines thus far have been very woolly and non-specific, which whilst I understand to a degree, is very and increasingly frustrating for investors who were expecting a summer launch. BAMS in particular seems to have dropped off the face of the earth since the July RNS update. Could you also confirm whether Avacta are under NDA from UK government with regard to price sensitive information such as LFT performance data?

Avacta is working with UK government programmes, as well as having now also put in place its own clinical and commercial collaborations, to evaluate and clinically validate the high throughput COVID-19 bead-assisted mass spectrometry (BAMS) laboratory assay developed with Adeptrix for CE marking as a professional use diagnostic test. The Company is aiming to have completed its initial clinical evaluation in the next few weeks and will then update shareholders on the timeline and route to market for the test in as much detail as commercial confidentiality will allow. The Company has also stated that it will provide the next update to the market on the lateral flow test, including a timeline to clinical validation and CE marking, when the first pilot batch goes into production.

Excellent posts Runner although it does seem strange you've just recently found your voice. If you're truly a lth then you must still believe in Avacta.

The next 5 weeks really are critical

Doh, when thoroughly questioned following the garage conversion which went months over to complete.. my missus said you have a way with words, you're very entertaining and have a limp dikc too ;)

Understood Pedrol I just wonder how you establish who is genuine on an anonymous chat facility

Is this just a board for positive outlook? No!

We had RK on here the other day saying if we're invested then we should be positive. Yes agreed BUT we should have all views. If you don't like someone or their views, use the filter.

No uneccessary long or well written solely positive views from me demanding 75+ likes. If you're one of the many to be invested here from May onwards, I'm guessing you're showing a paper loss like me. I prefer all views, even MOFOfreeman's

BAMS will no doubt lift the price if this news arrives first and asuming it's positive. We need to see deals and revenue. Cta should increase sp too by (complete guess) 10 to 20% being an inflection point (whatever that means). Braced for further short term volatility and all dependant on order of news. Check out the 6 month chart, complete roller-coaster, more to come

No bashing, not looking for an entry point and don't see the need to be continously positive when invested, more balanced. Let's be realistic, if the lfd here is as good as we hope the sp will fly and if its not then it will go considerably south. Don't need to be a genius to work that out

Who would take the vaccine made by a company who can't get the dosing right? Tick this up of so.

There's a real possibility won't publish any S&S before a full clinical validation is completed too.

Most useless poster on this board competition could get heated today. Where's Poundcake??

The document includes affimers. Chill out!

Hahahaha this kid makes me laugh

What bashers you muppet? They don't need to be here, we've lost around £100m market cap last few weeks